880267 | DSG-pSar25-Maleimide
1,2-distearoyl-sn-glycero-3-succinyl-N-polysarcosine-25-N-Maleimide
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
Info
DSG-pSar25-Maleimide
1,2-distearoyl-sn-glycero-3-succinyl-N-polysarcosine-25-N-Maleimide
| DSG-pSar25-Maleimide is a lipid that is composed of a DSG unit conjugated to a pSar25 polymer. Polysarcosine (pSar) lipids are offered as alternatives to traditional PEGylated lipids used in RNA delivery vehicles. Compared to similar PEGylated lipid nanoparticles (LNPs), pSar LNPs have shown improved mRNA transfection potency and improved safety profiles. This compound features a maleimide group enabling a highly versatile platform for bioconjugation. The maleimide group reacts with thiol groups on peptides, facilitating the attachment of bioactive molecules to the lipid nanoparticle surface. This unique capability allows for the creation of LNPs tailored for targeted delivery to specific cells. |
Data
No
No
| C121H207N27O32 |
>99%
1 year
-20°C
2552.14
2550.54
Powered by Bioz
